Pulmonary, Critical Care, and Sleep Medicine
Pulmonary, Critical Care, and Sleep Medicine Faculty
 |
Kamal Mubarak, MD, FCCP Assistant Professor Director, Pulmonary Vascular Disease Program Division of Pulmonary, Critical Care and Sleep Medicine Box 100225 University of Florida Health Science Center Gainesville, Florida 32610-0225 Phone: 352.273-8740 Email: mubarak@ufl.edu |
Educational Background
- Fellowship: Mayo Clinic, Rochester, MN
- Residency: Indiana University, Indianapolis, IN
Research Interests
- Vascular endothelium
- Transcription factors
- Clinical trials in pulmonary hypertension
Professional Societies
- American Thoracic Society
- American College of Chest Physicians
Publications (2006 onwards)
- Tashkin DP, Elashoff E, Clements PJ, Roth MD, Furst DE, Silver RM, Goldin J, Arriola E, Strange C, Bolster MB, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel D, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Khanna D, Li G, Li G. Effects of 1-Year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med. 2007 (In press)
- Khanna D, Yan X, Tashkin DP, Furst DE, Elashoff R, Roth MD, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Clements PJ. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum 2007.
- Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006.
- Kaddoum RN, Mubarak K, Chidiac EJ. Pulmonary hypertension and anesthesia. Middle East J Anesthesiol 2006.
- Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum 2005.
For a complete list of the publications,
Visit Pubmed, US National Library of Medicine (NLM)